Why Attend?

The field of clinical trials has encountered legal, technical, and regulatory challenges, both recent ones driven by initiatives to increase transparency, effectiveness, and equity and pre-existing ones accentuated by the rise of COVID-19. This conference will deconstruct complex issues to provide valuable insight on topics such as: clinical trial type, design, and labeling; clinical trial innovations, including machine learning and artificial intelligence; global expansion of clinical trials; clinical trial transparency, diversity, and patient engagement. It also will discuss practical tools, including statistics fundamentals, clinical trial funding, real world data and evidence usage, patient privacy, and due diligence to comply with increased clinical trial enforcement.

Register by October 7 and SAVE!


Industry & Firms

  • +$200 for non-members


  • +$100 for non-members


  • +$100 for non-members


  • +$100 for non-members


  • students registration


Employees and volunteers of 501(c)(3) patient or disease organizations are eligible to apply for a registration fee waiver. Applications are considered on a case-by-case basis. Please email Lauren Caroline Tadros Potter for more information.

Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.


Sponsorship opportunities are available. Please let us know if you would like more information.


Planning Committee

Jacqueline Berman, Morgan, Lewis & Bockius LLP
Elvira Cawthon, EAS Consulting Group
Margo Heath-Chiozzi, Celldex Therapeutics, Inc.
Minerva Hughes, FDA
John Kendzior, Reed Smith LLP
Geoffrey Levitt, DLA Piper LLP  
Brian Malkin, McDermott Will & Emery
Lance Shea, BakerHostetler
Carolina Wirth, Faegre Drinker Biddle & Reath LLP
Jonathan Walland, Pfizer